Literature DB >> 23295989

Neglected diseases see few new drugs despite upped investment.

Cassandra Willyard.   

Abstract

Mesh：

Year:  2013        PMID： 23295989     DOI： 10.1038/nm0113-2

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  2 in total

Review 1.  Drug development for neglected diseases: a deficient market and a public-health policy failure.

Authors:  Patrice Trouiller; Piero Olliaro; Els Torreele; James Orbinski; Richard Laing; Nathan Ford
Journal:  Lancet       Date:  2002-06-22       Impact factor: 79.321

2.  Development of and access to products for neglected diseases.

Authors:  Joshua Cohen; Maria Staroselsky Dibner; Andrew Wilson
Journal:  PLoS One       Date:  2010-05-12       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.